Atlas Trials

A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor

Clinical trial NCT06245018 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06245018
Sponsor
Nuwacell Biotechnologies Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Solid Tumor
Start date
2024-02-01
Primary completion
2027-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.